Get your fresh news on health and wellness in Mexico
Provided by AGP
AGP Picks
View all
Perspectify News
Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Filter
6 hours ago
Global Wheat Health Alliance launched to strengthen disease resistance in wheat
Indeterminate
International Maize and Wheat Improvement Center (CIMMYT)
Press releases
Publish your press release
13 hours ago
ICAIE Releases New Infographic: The Growing Threat Posed By Illicit Trade of Counterfeit Medicines in Mexico
EIN Presswire
Diversification by Cartels into Pharmaceuticals Expands the Lucrative Illicit Trade in the Americas WASHINGTON, DC, UNITED STATES, May 7, 2026 /EINPresswire.com/ -- ICAIE releases new May 2026 Infographic on illicit trade of counterfeit...
14 hours ago
R3 Stem Cell International Designated an Authorized Provider of Dezawa MuseCells® at All Mexico Locations
EIN Presswire
R3 Stem Cell International has been designated by MuseCell Innovations® with authorized access to Dezawa MuseCells® across the company’s Mexican clinic network.
17 hours ago
R3 Stem Cell Receives Trademark Registration for 'Regenerative Trifecta' Protocol Brand Across Its Global Clinic Network
EIN Presswire
R3 Stem Cell's trademark for "Regenerative Trifecta" formalizes the brand identity of a clinical protocol used across the eighty-clinic, eight-country network.
May. 6, 2026
John B. Sanfilippo & Son, Inc. Voluntarily Recalls Snack Mix Products Due to Possible Health Risk
U.S. Food and Drug Administration
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service.
May. 6, 2026
John B. Sanfilippo & Son, Inc. Voluntarily Recalls Snack Mix Products Due to Possible Health Risk
U.S. Food and Drug Administration
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service.
May. 6, 2026
Global RNA Targeting Small Molecule Drug Discovery Market Size/Share Worth USD 17.6 Billion by 2035 at a 22.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)
GlobeNewswire, Inc.
Austin, TX, USA, May 06, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “RNA Targeting Small Molecule Drug Discovery Market Size, Trends and Insights By Indication (Cancer, Metabolic Diseases, Infectious...
Video Stories
Discover Affinity Group Publishing
Sign up for:
Mexico Health Insider
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.
Explore More
